These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 10968300)
21. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]
23. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history. Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810 [TBL] [Abstract][Full Text] [Related]
24. Concentration and avidity of anti-tetanus antibodies in mother-infant pairs: relation to immunization time. Abacioğlu YH; Eskişar T; Yuluğ N FEMS Immunol Med Microbiol; 1995 Jul; 11(4):273-7. PubMed ID: 8541804 [TBL] [Abstract][Full Text] [Related]
25. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. Krüger S; Seyfarth M; Sack K; Kreft B Vaccine; 1999 Mar; 17(9-10):1145-50. PubMed ID: 10195626 [TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid. Cavuslu S; Oncul O; Altunay H; Ozsoy MF; Kocak N Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):431-3. PubMed ID: 12884073 [TBL] [Abstract][Full Text] [Related]
27. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis). Lau RC Epidemiol Infect; 1988 Oct; 101(2):405-10. PubMed ID: 2903065 [TBL] [Abstract][Full Text] [Related]
28. [Investigation of the immunity status towards tetanus of a population of mechanics at the car-factory "Renault" (author's transl)]. Bizzini B; Champigneux P; Guyotjeannin C; Lebreton P; Tisseuil H; Chevalier J; Blaise F; Thurel C; Turpin A Ann Microbiol (Paris); 1978 Oct; 129 B(3):437-49. PubMed ID: 371480 [TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of tetanus antibodies among adults older than 65 years. Alagappan K; Rennie W; Kwiatkowski T; Falck J; Silverstone F; Silverman R Ann Emerg Med; 1996 Jul; 28(1):18-21. PubMed ID: 8669732 [TBL] [Abstract][Full Text] [Related]
30. [Immune reaction to tetanus in the elderly: what is the duration of vaccine protection?]. Steger MM; Maczek C; Berger P; Grubeck-Loebenstein B Wien Klin Wochenschr; 1997 Oct; 109(19):767-70. PubMed ID: 9441523 [TBL] [Abstract][Full Text] [Related]
31. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants. Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224 [TBL] [Abstract][Full Text] [Related]
32. Antibody response to a single tetanus toxoid booster in young women in rural south India. Aruldas K; Muliyil JP; Mathai E; Abraham S; Joseph A; Inbamalar U; Aruldas V Natl Med J India; 2001; 14(1):22-3. PubMed ID: 11242693 [TBL] [Abstract][Full Text] [Related]
33. Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. Nielsen HJ; Mortensen T; Holten-Andersen M; Brünner N; Sørensen S; Rask-Madsen J Scand J Gastroenterol; 2001 Mar; 36(3):265-9. PubMed ID: 11305513 [TBL] [Abstract][Full Text] [Related]
34. Antibody protection to diphtheria in geriatric patients: need for ED compliance with immunization guidelines. Alagappan K; Rennie W; Kwiatkowski T; Narang V Ann Emerg Med; 1997 Oct; 30(4):455-8. PubMed ID: 9382241 [TBL] [Abstract][Full Text] [Related]
35. Liposomes as immunological adjuvants for tetanus vaccine. Popescu C; Durbaca S; Ivanov D Roum Arch Microbiol Immunol; 1998; 57(3-4):263-9. PubMed ID: 11845438 [TBL] [Abstract][Full Text] [Related]
36. Overdose of booster tetanus toxoid given in error: a clinical study. Melamed I; Romem Y; Shimoni T; Perek Y; Dolev E Scand J Infect Dis; 1983; 15(3):303-6. PubMed ID: 6359374 [TBL] [Abstract][Full Text] [Related]
37. Community-based seroepidemiology of tetanus in three selected provinces in Turkey. Kurtoglu D; Gozalan A; Coplu N; Miyamura K; Morita M; Esen B; Akin L Jpn J Infect Dis; 2004 Feb; 57(1):10-6. PubMed ID: 14985630 [TBL] [Abstract][Full Text] [Related]
38. Specific in vivo and in vitro antibody response to tetanus toxoid immunization. Ershler WB; Moore AL; Hacker MP Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720 [TBL] [Abstract][Full Text] [Related]
39. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Girndt M; Pietsch M; Köhler H Am J Kidney Dis; 1995 Sep; 26(3):454-60. PubMed ID: 7645553 [TBL] [Abstract][Full Text] [Related]
40. Tetanus antibodies at booking in a Nigerian obstetric population. Okafor GO; Gini PC Afr J Med Med Sci; 1994 Mar; 23(1):19-22. PubMed ID: 7839940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]